Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.

Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
The Journal of Immunology (Impact Factor: 5.36). 12/2008; 181(10):7254-62. DOI: 10.4049/jimmunol.181.10.7254
Source: PubMed

ABSTRACT Microglial activation is an important pathological component in brains of patients with Alzheimer's disease (AD), and fibrillar amyloid-beta (Abeta) peptides play an important role in microglial activation in AD. However, mechanisms by which Abeta peptides induce the activation of microglia are poorly understood. The present study underlines the importance of TLR2 in mediating Abeta peptide-induced activation of microglia. Fibrillar Abeta1-42 peptides induced the expression of inducible NO synthase, proinflammatory cytokines (TNF-alpha, IL-1beta, and IL-6), and integrin markers (CD11b, CD11c, and CD68) in mouse primary microglia and BV-2 microglial cells. However, either antisense knockdown of TLR2 or functional blocking Abs against TLR2 suppressed Abeta1-42-induced expression of proinflammatory molecules and integrin markers in microglia. Abeta1-42 peptides were also unable to induce the expression of proinflammatory molecules and increase the expression of CD11b in microglia isolated from TLR2(-/-) mice. Finally, the inability of Abeta1-42 peptides to induce the expression of inducible NO synthase and to stimulate the expression of CD11b in vivo in the cortex of TLR2(-/-) mice highlights the importance of TLR2 in Abeta-induced microglial activation. In addition, ligation of TLR2 alone was also sufficient to induce microglial activation. Consistent to the importance of MyD88 in mediating the function of various TLRs, antisense knockdown of MyD88 also inhibited Abeta1-42 peptide-induced expression of proinflammatory molecules. Taken together, these studies delineate a novel role of TLR2 signaling pathway in mediating fibrillar Abeta peptide-induced activation of microglia.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The 5XFAD early onset mouse model of Alzheimer's disease (AD) is gaining momentum. Behavioral, electrophysiological and anatomical studies have identified age-dependent alterations that can be reminiscent of human AD. However, transcriptional changes during disease progression have not yet been investigated. To this end, we carried out a transcriptomic analysis on RNAs from the neocortex and the hippocampus of 5XFAD female mice at the ages of one, four, six and nine months (M1, M4, M6, M9).
    Molecular Neurodegeneration 09/2014; 9(1):33. · 5.29 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Neurodegenerative diseases are characterized by the loss of specific neuronal populations. Epidemiological studies and pathologycal analyses have demonstrated the existence of a link between mutations in specific genes and heritable forms of neurodegenerative diseases. Although some of these mutations can be found in higher frequency among certain ethnic populations, together they account for only a small percentage of all cases. Therefore, at the present it is well accepted that the causes of idiopathic or non-familial forms of neurodegenerative diseases are multifactorial, including genetic predisposition, epigenetic factors, age, and even environmental factors. Although the key molecular and cellular events underlying the development of neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's and multiple sclerosis, are clearly different, a common feature between them is neuroinflammation. In this context, the central nervous system has long been considered to be an immuneprivileged site because of the presence of the blood–brain barrier and the lack of a lymphatic system, still it is now well established that it is fully capable of mounting an inflammatory response. Invading pathogens, trauma, stroke, intraneural as well as extracellular fibrillary material can trigger local invasion of circulating immune cells, production of reactive oxygen and nitrogen species, as well as the activation of the brain resident macrophages known as microglia. Inflammation in the central nervous system has been appropriately described as a two-edged sword; in acute situations inflammatory mechanisms limit injury and promotes healing; however, in a chronic situation neuroinflammation can seriously damage viable host tissue. Current studies support the notion that neuroinflammation promotes or facilitates neurodegeneration; therefore, early intervention with antiinflammatory therapies in populations identified to be at risk due to genetic mutations may represent a valuable tool. We present recent data regarding non-genetic mechanisms that regulate the development of neurological disorders including Huntington’s disease, multiple sclerosis, Parkinson’s disease and Alzheimer’s disease.
    Molecular Aspects of Inflammation, 11/2013: chapter Neurodegenerative disorders and inflammation: pages 173-207; Research Signpost., ISBN: 978-81-308-0528-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson Disease (PD) is a chronic and progressive neurodegenerative disorder of unknown etiology. Autopsy findings, genetics, retrospective studies, and molecular imaging all suggest a role for inflammation in the neurodegenerative process. However, relatively little is understood about the causes and implications of neuroinflammation in PD. Understanding how inflammation arises in PD, in particular the activation state of cells of the innate immune system, may provide an exciting opportunity for novel neuroprotective therapeutics. We analyze the evidence of immune system involvement in PD susceptibility, specifically in the context of M1 and M2 activation states. Tracking and modulating these activation states may provide new insights into both PD etiology and therapeutic strategies. Copyright © 2014. Published by Elsevier Ltd.
    Neuroscience 11/2014; · 3.33 Impact Factor


1 Download
Available from